| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| bevacizumab + rituximab | leukocyte surface antigen leu-16 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Lymphoma[MeSHID:D008223] |
NA | phase 3 | unknown |
| bevacizumab + rituximab | vascular endothelial growth factor a | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Lymphoma[MeSHID:D008223] |
NA | phase 3 | unknown |
| click here to return to the previous page | ||||||||